Steven Krilis

Publications

• McNeil, H.P., Simpson, R.J., Chesterman, C.N., Krilis, S.A."Anti-phospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: β2-glycoprotein I " Proceedings of the National Academy of Sciences of the United States of America, 87, pp. 4120–4124. Cited 920 times.
• McNeil, H.P., Chesterman, C.N., Krilis, S.A. "Immunology and clinical importance of antiphospholipid antibodies" Advances in Immunology, 49, pp. 193–280. Cited 284 times.
• Hunt, J., Krilis, S. "The fifth domain of β2-glycoprotein I contains a phospholipid binding site and a region recognized by anticardiolipin antibodies" Journal of Immunology, 152, pp. 653–659. Cited 195 times.
• Hunt, J.E., McNeil, H.P., Morgan, G.J., Crameri, R.M., Krilis, S.A. "A phospholipid-beta 2-glycoprotein I complex is an antigen for anticardiolipin antibodies occurring in autoimmune disease but not with infection." Lupus 1, pp. 75–81. Cited 147 times.
• Miyakis, S., Lockshin, M.D., Atsumi, T., Branch, D.W., Brey, R.L., Cervera, R., Derkesen, R.H.W.M., De Groot, P.G., Koike, T., Meroni, P.L., Reber, G., Shoenfeld, Y., Tincani, A., Vlachoyiannopoulos, P.G., Krilis, S.A. "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome " Journal of Thrombosis and Haemostasis 4, pp. 295–306. Cited 116 times.
• Hunt, J.E., Simpson, R.J., Krilis, S.A. "Identification of a region of β2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity" Proceedings of the National Academy of Sciences of the United States of America 90, pp. 2141–2145. Cited 111 times.